Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study

Iben F Sorgenfrei, Kathrine Norrild, Per Bo Larsen, Jakob Stensballe, Doris Ostergaard, Martine E Prins, Jørgen Viby-Mogensen

312 Citations (Scopus)

Abstract

Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
Original languageEnglish
JournalAnesthesiology
Volume104
Issue number4
Pages (from-to)667-74
Number of pages8
ISSN0003-3022
Publication statusPublished - 1 Apr 2006

Keywords

  • Adolescent
  • Adult
  • Androstanols
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Blockade
  • Neuromuscular Nondepolarizing Agents
  • gamma-Cyclodextrins

Fingerprint

Dive into the research topics of 'Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study'. Together they form a unique fingerprint.

Cite this